Zhenchong Xiong

765 total citations
27 papers, 498 citations indexed

About

Zhenchong Xiong is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Zhenchong Xiong has authored 27 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 10 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Zhenchong Xiong's work include Cancer Immunotherapy and Biomarkers (5 papers), Breast Cancer Treatment Studies (5 papers) and Epigenetics and DNA Methylation (4 papers). Zhenchong Xiong is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Breast Cancer Treatment Studies (5 papers) and Epigenetics and DNA Methylation (4 papers). Zhenchong Xiong collaborates with scholars based in China and Australia. Zhenchong Xiong's co-authors include Xinhua Xie, Guangzheng Deng, Xing Li, Zeyu Shuang, Xinjian Huang, Xiaoming Xie, Xi Wang, Jin Wang, Lin Yang and Xi Wang and has published in prestigious journals such as Oncogene, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Zhenchong Xiong

26 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenchong Xiong China 12 243 224 206 105 60 27 498
Yang Peng China 13 206 0.8× 228 1.0× 204 1.0× 123 1.2× 30 0.5× 44 485
Mariangela Balistreri Italy 10 124 0.5× 270 1.2× 219 1.1× 89 0.8× 46 0.8× 15 487
Shanqi Xu China 10 242 1.0× 218 1.0× 189 0.9× 103 1.0× 37 0.6× 16 460
Valeria Pusceddu Italy 12 238 1.0× 135 0.6× 103 0.5× 72 0.7× 62 1.0× 45 382
Kemin Jin China 10 249 1.0× 205 0.9× 121 0.6× 79 0.8× 31 0.5× 34 502
Qiongyan Zou China 12 112 0.5× 256 1.1× 255 1.2× 59 0.6× 52 0.9× 35 441
Jennifer Hanson Canada 11 206 0.8× 294 1.3× 270 1.3× 103 1.0× 71 1.2× 20 562
Françoise Beltjens France 10 305 1.3× 82 0.4× 161 0.8× 120 1.1× 51 0.8× 32 469
Cristina Niccoli Italy 11 150 0.6× 156 0.7× 129 0.6× 140 1.3× 46 0.8× 19 393
Golareh Habibi Canada 5 241 1.0× 430 1.9× 151 0.7× 45 0.4× 42 0.7× 7 582

Countries citing papers authored by Zhenchong Xiong

Since Specialization
Citations

This map shows the geographic impact of Zhenchong Xiong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenchong Xiong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenchong Xiong more than expected).

Fields of papers citing papers by Zhenchong Xiong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenchong Xiong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenchong Xiong. The network helps show where Zhenchong Xiong may publish in the future.

Co-authorship network of co-authors of Zhenchong Xiong

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenchong Xiong. A scholar is included among the top collaborators of Zhenchong Xiong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenchong Xiong. Zhenchong Xiong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaojun, et al.. (2024). Breast Cancer Patient Flap Management After Mastectomy: A Best Practice Implementation Project. Clinical Breast Cancer. 25(1). 46–55.
2.
He, Wenzhuo, et al.. (2024). Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British Journal of Cancer. 131(2). 334–346. 3 indexed citations
3.
Xiong, Zhenchong, Lin Yang, Chao Zhang, et al.. (2024). MANF facilitates breast cancer cell survival under glucose-starvation conditions via PRKN-mediated mitophagy regulation. Autophagy. 21(1). 80–101. 9 indexed citations
4.
Yang, Lin, Shousheng Liu, Wenzhuo He, Zhenchong Xiong, & Liangping Xia. (2023). Characterisation of tumor microenvironment and prevalence of CD274/PD-L1 genetic alterations difference in colorectal Cancer. BMC Cancer. 23(1). 221–221. 2 indexed citations
6.
Zhong, Wenjing, Yunting Jian, Chao Zhang, et al.. (2023). SHC4 orchestrates β-catenin pathway-mediated metastasis in triple-negative breast cancer by promoting Src kinase autophosphorylation. Cancer Letters. 582. 216516–216516. 6 indexed citations
7.
Xiong, Zhenchong, Xing Li, Lin Yang, et al.. (2022). Integrative Analysis of Gene Expression and DNA Methylation Depicting the Impact of Obesity on Breast Cancer. Frontiers in Cell and Developmental Biology. 10. 818082–818082. 6 indexed citations
8.
Xiong, Zhenchong, Lin Yang, Juan Ao, et al.. (2022). A Prognostic Model for Breast Cancer Based on Cancer Incidence-Related DNA Methylation Pattern. Frontiers in Genetics. 12. 814480–814480. 1 indexed citations
9.
Li, Jianxia, Zhenchong Xiong, Xinjian Huang, et al.. (2022). Peripheral blood lymphocytes subtypes as new predictors for neoadjuvant therapy efficacy in breast cancer. Cancer Medicine. 11(15). 2923–2933. 2 indexed citations
10.
Yang, Lin, Shousheng Liu, Zhenchong Xiong, et al.. (2020). Changes in colorectal cancer incidence by site and age from 1973 to 2015: a SEER database analysis. Aging Clinical and Experimental Research. 33(7). 1937–1946. 7 indexed citations
11.
Xie, Xinhua, Xinhua Xie, Zhenchong Xiong, et al.. (2019). Nomogram to Predict Internal Mammary Lymph Nodes Metastasis in Patients With Breast Cancer. Frontiers in Oncology. 9. 1193–1193. 6 indexed citations
12.
Zou, Yutian, Shaoquan Zheng, Weikai Xiao, et al.. (2019). circRAD18 sponges miR-208a/3164 to promote triple-negative breast cancer progression through regulating IGF1 and FGF2 expression. Carcinogenesis. 40(12). 1469–1479. 72 indexed citations
13.
Xie, Xinhua, Xinhua Xie, Jianwei Wang, et al.. (2018). Identification of a 4‐mRNA metastasis‐related prognostic signature for patients with breast cancer. Journal of Cellular and Molecular Medicine. 23(2). 1439–1447. 25 indexed citations
14.
Ye, Liping, Feng‐Yan Li, Yipeng Song, et al.. (2018). Overexpression of CDCA7 predicts poor prognosis and induces EZH2‐mediated progression of triple‐negative breast cancer. International Journal of Cancer. 143(10). 2602–2613. 40 indexed citations
15.
Xiong, Zhenchong, Guangzheng Deng, Xinjian Huang, et al.. (2018). Score for the Survival Probability in Metastasis Breast Cancer: A Nomogram-Based Risk Assessment Model. Cancer Research and Treatment. 50(4). 1260–1269. 19 indexed citations
16.
17.
Yang, Lin, Zhenchong Xiong, Qian Xie, et al.. (2018). Second primary colorectal cancer after the initial primary colorectal cancer. BMC Cancer. 18(1). 931–931. 17 indexed citations
18.
Yang, Lin, Zhenchong Xiong, Wenzhuo He, et al.. (2018). Proximal shift of colorectal cancer with increasing age in different ethnicities. Cancer Management and Research. Volume 10. 2663–2673. 13 indexed citations
19.
Xiong, Zhenchong, Guangzheng Deng, Xinjian Huang, et al.. (2018). Bone metastasis pattern in initial metastatic breast cancer: a population-based study. Cancer Management and Research. Volume 10. 287–295. 92 indexed citations
20.
Lin, Chuyong, Wenting Liao, Yunting Jian, et al.. (2017). CGI-99 promotes breast cancer metastasis via autocrine interleukin-6 signaling. Oncogene. 36(26). 3695–3705. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026